Divi's Laboratories Ltd.

3452.55 +87.80 ▲2.6%

28 March 2024, 04:01:00 PM
Volume: 69,822

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.divislabs.com
Market Cap 91,234.91 Cr.
Enterprise Value(EV) 87,625.91 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 52.10 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 65.97 Trailing Twelve Months Ending 2023-12
Industry PE 41.54 Trailing Twelve Months Ending 2023-12
Book Value / Share 491.02 Trailing Twelve Months Ending 2023-12
Price to Book Value 7.00 Calculated using Price: 3,436.75
Dividend Yield 0.87 Period Ending 2023-03
No. of Shares Subscribed 26.55 Cr. 265,468,580 Shares
FaceValue 2
About Divi's Laboratories Ltd.
The Company is engaged in the manufacture of Active Pharmaceutical ingredients (API’s), Intermediates and Nutraceutical ingredients with predominance in exports. In addition to generic business, the Company, through its custom synthesis business, supports innovator pharma companies for their patented products business right from gram scale requirements for clinical trials to launch as well as late life cycle management.

Divi's Laboratories Ltd. Delivery

Delivered Qty
Traded Qty

Divi's Laboratories Ltd. Performance

1 Day
+2.61%
1 Week
+0.58%
1 Month
-2.41%
3 Month
-11.12%
6 Month
-8.33%
1 Year
+22.05%
2 Year
-22.53%
5 Year
+107.39%
10 Year
+415.54%

Divi's Laboratories Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 26.37 28.91 21.98 15.55 21 19.3 23.9 28.16 14.89
Return on Capital Employed (%) 33.06 35.57 28.75 21.68 28.5 25.36 32.07 35.06 19.36
Return on Assets (%) 18.21 22.49 17.21 11.12 15.78 15.11 19.07 22.77 12.37

Divi's Laboratories Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 3,495 4,293 5,357 5,925 6,957 7,310 9,295 11,728 12,767 12,677
Non Curr. Liab. 842 85 1,412 1,769 991 295 364 437 556 582
Curr. Liab. 776 520 659 653 847 1,821 1,728 2,454 1,533 1,011
Minority Int.
Equity & Liab. 5,112 4,898 7,429 8,347 8,795 9,425 11,387 14,619 14,857 14,270
Non Curr. Assets 2,340 1,871 3,418 3,812 4,145 3,851 4,596 5,009 5,113 5,388
Curr. Assets 2,772 3,027 4,011 4,535 4,650 5,574 6,791 9,610 9,744 8,882
Misc. Exp. not W/O
Total Assets 5,112 4,898 7,429 8,347 8,795 9,425 11,387 14,619 14,857 14,270

Divi's Laboratories Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 3,115 3,776 4,064 3,891 4,946 5,394 6,969 8,960 7,768 7,493
Other Income 45 97 75 113 156 190 63 116 345 328
Total Income 3,160 3,874 4,139 4,005 5,102 5,584 7,032 9,076 8,112 7,821
Total Expenditure -1,949 -2,358 -2,617 -2,629 -3,073 -3,571 -4,108 -5,079 -5,398 -5,533
PBIDT 1,211 1,516 1,522 1,376 2,029 2,013 2,924 3,997 2,714 2,288
Interest -3 -5 -3 -2 -5 -7 -2 -2 -2 -1
Depreciation -136 -118 -123 -142 -169 -186 -256 -312 -343 -370
Taxation -221 -267 -335 -354 -502 -443 -682 -723 -545 -534
Exceptional Items
PAT 852 1,126 1,060 877 1,353 1,377 1,984 2,960 1,823 1,383
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 852 1,126 1,060 877 1,353 1,377 1,984 2,960 1,823 1,383
Adjusted EPS 32 42 40 33 51 52 75 112 69 52

Divi's Laboratories Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 557 826 1,038 1,150 776 954 1,216 1,947 1,912 2,460
Cash Fr. Inv. -305 -521 -406 -1,140 -478 -685 -83 75 -2,195 -2,708
Cash Fr. Finan. -249 -303 -631 2 -314 -246 -1,091 -35 -532 -797
Net Change 3 3 0 13 -17 23 41 1,987 -816 -1,045
Cash & Cash Eqvt 15 18 18 -4 -21 2 43 2,030 1,215 170

Divi's Laboratories Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 51.95 51.94 51.94 51.94 51.94 51.94 51.93 51.93 51.92
Public 48.05 48.06 48.06 48.06 48.06 48.06 48.07 48.07 48.08
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Divi's Laboratories Ltd. Announcements

Tue, 05 Mar 2024
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement relating to Postal Ballot Notice
Mon, 04 Mar 2024
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Submission of Postal Ballot Notice dated February 10 2024.
Fri, 16 Feb 2024
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
We herewith enclose the Transcript of earnings conference call held on February 10 2024.

Divi's Laboratories Ltd. Technical Scans

Thu, 28 Mar 2024
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Opening at Low Opening at Low
Closing Above Previous High Closing Above Previous High

Divi's Laboratories Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 388,812.23 1,620.50 +0.8%
Cipla Ltd. 120,673.12 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. 102,679.14 6,171.85 +2.0%
Zydus Lifesciences Ltd. 101,151.67 1,007.35 +0.8%
Mankind Pharma Ltd. 92,029.19 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. 91,330.58 6,347.35 +1.9%
Torrent Pharmaceuticals Ltd. 88,034.74 2,513.00 -2.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 43.66 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-12 32.54 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.64 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 34.01 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-12 53.29 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 115.71 6,347.35 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 58.93 2,513.00 -2.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 6.23 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-12 4.66 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.82 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.37 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-12 10.36 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.52 6,347.35 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.31 2,513.00 -2.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 0.02 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,347.35 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,513.00 -2.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 12.85 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,347.35 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,513.00 -2.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 12.85 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,347.35 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,513.00 -2.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,347.35 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,513.00 -2.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,347.35 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,513.00 -2.0%

Divi's Laboratories Ltd. FAQ's

What is Divi's Lab share price?

Can I buy Divi's Lab shares now?

What is the Dividend Yield of Divi's Lab?

What is the Market Cap of Divi's Lab?

What are the key metrics to analyse Divi's Lab?

What is the 52 Week High and Low of Divi's Lab?

What is the trend of Divi's Lab share price?